Recruiting Genomic Profiling in Cancer Patients NCT01775072 Conditions Hematologic Cancers, Hematologic Diseases, Hematologic Neoplasms, +4 more Locations St. Vincent (Data Collection Only) — Bridgeport, Connecticut, United States Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut, United States Norwalk Hospital — Norwalk, Connecticut, United States Baptist Alliance MCI — Miami, Florida, United States View all 18 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1 NCT02034981 Conditions Hematologic Cancers, Metastatic Cancer, Neoplasm Metastasis, +5 more Locations Gustave Roussy — Villejuif, Île-de-France Region, France View Trial Details
Completed Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers NCT03512340 Conditions Advanced Solid Cancers, Hematologic Cancers, Hematologic Diseases, +4 more Locations Research Site 002 — New York, United States Research Site 001 — San Antonio, Texas, United States Research Site 101 — Toronto, Ontario, Canada View Trial Details
Active, Not Recruiting Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations NCT02304809 Conditions Hematologic Cancers, Metastatic Cancers, Neoplasm Metastasis, +5 more Locations Tredaniel — Paris, France View Trial Details
